Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing

PRLDPress release2026-01-30 08:00

Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing. This marks a pivotal step towards the production of pilot units intended for the upcoming clinical performance study. BioStock reached out to Paul Monaghan, Head of Engineering, to learn more.

Read the full article here: https://biostock.se/en/2026/01/prolight-slutfor-instrumentdesign-och-forbereder-for-pilottillverkning/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.

The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.